Lionco Pharmaceutical Group Co.,Ltd. reported earnings results for the nine months ended September 30, 2022. For the nine months, the company reported sales was CNY 251.21 million compared to CNY 653.97 million a year ago. Revenue was CNY 251.21 million compared to CNY 653.97 million a year ago.

Net loss was CNY 69.47 million compared to net income of CNY 78.88 million a year ago. Basic loss per share from continuing operations was CNY 0.1 compared to basic earnings per share from continuing operations of CNY 0.11 a year ago.